Overview of Companion Diagnostics MarketThe Companion Diagnostics Market is evolving rapidly, driven by the growing demand ...

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalenc ...

Request To Download Free Sample of This Strategic Report @- Cardiovascular genetic testing enables clinicians and patients to identify inherited risks for a wide range of cardiac disorders, including ...

According to Research by SNS Insider, U.S. Cancer Biomarkers Market to Surpass USD 22.70 Billion by 2032 Due to Rising Investment in Personalized Cancer Diagnostics.Austin, July 21, 2025 (GLOBE ...

British scientists have created eight children in a lab over the past two years whose health continues to be monitored in hopes of determining if research methods that incorporate a third parent in ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Dustin 'The Diamond' Poirier's final UFC fight at UFC 318 will be against Max Holloway for the BMF title in his hometown of ...

What are Uterine fibroids? What women need to know as Lupita Nyong’o opens up about her struggles in a moving Instagram post.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Industry-leading expertise helps businesses qualify for cyber insurance and secure discounts on risk-reducing Managed ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it ...

According to analysts at Vantage Market Research, the Global Prostate Specific Antigen (PSA) Testing Market size is worth USD ...